 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
84 News |  |
| «12 |
- pixatimod (PG545) / Zucero Therap
Trial primary completion date, Metastases: Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours (clinicaltrials.gov) - Nov 25, 2014
P1, N=25, Recruiting, Sponsor: Progen Pharmaceuticals
Trial primary completion date: Dec 2014 --> May 2015
- | pixatimod (PG545) / Zucero Therap
New P1 trial, Metastases: Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours (clinicaltrials.gov) - Jan 21, 2014
P1, N=25, Recruiting, Sponsor: Progen Pharmaceuticals
- pixatimod (PG545) / Zucero Therap
Enrollment open, Metastases: Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours (clinicaltrials.gov) - Jan 19, 2014
P1, N=25, Recruiting, Sponsor: Progen Pharmaceuticals
Trial primary completion date: Dec 2014 --> May 2015 Not yet recruiting --> Recruiting